Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 4/20 | 0.32 |
| ▸ | MAOA | P21397 | 4/20 | 0.32 |
| ▸ | MAOB | P27338 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7511837 | 0.76 | KDM1A (0.40) | KDM1AMAOAMAOB | |
| SCHEMBL1577842 | 0.76 | HTR2A (0.41) | KDM1AMAOAMAOB | |
| SCHEMBL7427186 | 0.74 | KDM1A (0.39) | KDM1AMAOAMAOB | |
| SCHEMBL7077759 | 0.72 | KDM1A (0.38) | KDM1AMAOAMAOB | |
| SCHEMBL7199456 | 0.72 | CHRNA7 (0.41) | KDM1AMAOAMAOB | |
| SCHEMBL2390258 | 0.71 | HTR2C (0.32) | KDM1AMAOAMAOB | |
| SCHEMBL1074533 | 0.71 | KDM1A (0.40) | KDM1AMAOAMAOB | |
| SCHEMBL7985531 | 0.71 | HTR2C (0.32) | KDM1AMAOAMAOB | |
| SCHEMBL222998 | 0.71 | CHRNA7 (0.35) | KDM1AMAOAMAOB | |
| SCHEMBL3625731 | 0.71 | CYP2C19 (0.35) | KDM1AMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10166530-B2 | Use of certain transition metal hyperaccumulator plants for reducing organic compounds in a green manner | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2019-01-01 | — | — | US | disclosed |
| EP-3177399-A1 | USE OF CERTAIN TRANSITION METAL HYPERACCUMULATOR PLANTS FOR REDUCING ORGANIC COMPOUNDS IN A GREEN MANNER | CNRS (Centre National de la Recherche Scientifique) (FR) | 2017-06-14 | — | — | EP | disclosed |
| US-20170157594-A1 | USE OF CERTAIN TRANSITION METAL HYPERACCUMULATOR PLANTS FOR REDUCING ORGANIC COMPOUNDS IN A GREEN MANNER | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2017-06-08 | — | — | US | disclosed |
| WO-2016009116-A1 | USE OF CERTAIN TRANSITION METAL HYPERACCUMULATOR PLANTS FOR REDUCING ORGANIC COMPOUNDS IN A GREEN MANNER | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2016-01-21 | — | — | WO | disclosed |
| US-7208614-B2 | Method for producing, via organometallic compounds, organic intermediate products | ARCHIMICA GMBH (DE) | 2007-04-24 | — | — | US | disclosed |
| US-20050001333-A1 | Method for producing, via organometallic compounds, organic intermediate products | ARCHIMICA GMBH (DE) | 2005-01-06 | — | — | US | disclosed |
| US-20040251563-A1 | Method for poducing, via organometallic compounds, organic intermediate products | EUTICALS GMBH (DE) | 2004-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10166530-B2 | Use of certain transition metal hyperaccumulator plants for reducing organic compounds in a green manner | SLC39A3, OAT, GLB1 | KDM1A 3026/4885MAOA 367/4885MAOB 291/4885 |
| US-20170157594-A1 | USE OF CERTAIN TRANSITION METAL HYPERACCUMULATOR PLANTS FOR REDUCING ORGANIC COMPOUNDS IN A GREEN MANNER | SLC39A3, OAT, GLB1 | KDM1A 3026/4885MAOA 367/4885MAOB 291/4885 |
| US-20050001333-A1 | Method for producing, via organometallic compounds, organic intermediate products | NISCH, HDHD5, TYR | KDM1A 3222/4885MAOA 230/4885MAOB 171/4885 |
| US-20040251563-A1 | Method for poducing, via organometallic compounds, organic intermediate products | ROS1, AOC3, NOX4 | KDM1A 718/4885MAOA 465/4885MAOB 484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.